Having closed a $30m financing round, Gelesis is now planning to submit its anti-obesity hydrogel pill for US pre-market approval and CE mark authorization this year and start preparing for commercialization.
Gelesis100 is the first product to emerge from Gelesis' hydrogel platform. The product consists of orally-administered capsules, each containing small hydrogel particles made from two natural components that form a...